Update on the timeline for Vifor Pharma tender offer

▤ Summary

CSL has previously advised that it expected to be in a position to close the acquisition of Vifor Pharma AG by June 2022. CSL and Vifor Pharma are continuing to work closely with the respective remaining competition authorities in their review of the tender offer. The company is a partner of choice for pharmaceuticals and innovative patient-focused solutions across iron, dialysis, nephrology and rare conditions. Vifor Pharma Group strives to help patients around the world with severe, chronic and rare diseases lead better, healthier lives. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care.

▦ Linked Companies